Search

everythinglearnresearchcommunity

for

Search:↓

Skin changes help detect graft-versus-host reaction early after bone marrow transplants.

A woman's sudden hair loss three years after a bone marrow transplant was a sign of chronic graft-versus-host disease but improved with treatment.

Skin problems are common after stem cell transplants, and early treatment by dermatologists can improve patient outcomes.

Toxic Epidermal Necrolysis is a rare, serious skin condition that can affect anyone, is more common in women, and may be linked to genetics, with a 20% mortality rate mainly due to sepsis.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

Ruxolitinib helps protect skin stem cells and keeps skin healthy in mice with skin GVHD.

Chemotherapy can cause various skin reactions, with hair loss being the most common, and proper diagnosis and treatment of these reactions are important.

Some drugs can cause skin reactions, which may improve when the drug is stopped, and rapid diagnosis and stopping the drug is crucial.

Chemotherapy and cytokine therapy can cause various skin reactions, including hair loss and hypersensitivity.

Toxic epidermal necrolysis is a severe skin reaction often linked to drugs, requiring careful medication use and supportive care.

Some drugs can cause skin, nail, and hair problems, which are important for healthcare professionals to recognize and report.

Dog skin with hair loss, when transplanted to mice, regrew hair, suggesting the hair loss cause is likely body-wide, not skin-specific.

Chemotherapy can cause skin problems like hair loss, mouth sores, and skin darkening, and recognizing these can affect treatment decisions.

Hormone imbalances can cause skin diseases, and understanding these links is important for diagnosis and treatment.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Special fiber materials boost the healing properties of certain stem cells.

The document concludes that accurate diagnosis of different types of hair loss requires careful examination of hair and scalp tissue, considering both clinical and microscopic features.

Steven Kossard classified lymphocyte-related hair loss into four patterns, each linked to different types of baldness.

Pediatric transplant patients often experience unique skin changes mainly due to medication use.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

Toxic epidermal necrolysis is a severe skin condition often caused by drugs, with complex treatment and a high risk of death, but survivors usually heal without scars.

Hair usually grows back 1-3 months after treatment for anagen effluvium, and children with Loose Anagen Hair Syndrome often improve by adolescence.

Hair loss can indicate underlying systemic diseases and addressing these can sometimes reverse the hair loss.

The document concludes that recognizing and properly diagnosing lipodystrophy syndromes is crucial for effective management and treatment.

Many patients find hair loss from chemotherapy very distressing, and while treatments like minoxidil and scalp cooling may help, there is no sure way to prevent it.

Autoimmune diseases can cause hair loss, and early treatment is important to prevent permanent damage.

Chemotherapy can cause rapid, extensive hair loss, with patterns varying between individuals.

The document concludes that parathyroid diseases have a range of clinical features and outcomes, with some conditions being treatable and others having a high risk of mortality.

Two teenage brothers had a rare, treatment-resistant form of female-pattern hair loss with unusual scalp changes.

JAK inhibitors, like baricitinib, are effective and safe for treating alopecia areata.